Clinical Study Results
Adverse reactions during the study (Groups 6 through 10)
Group 6 Group 7 Group 8 Group 9 Group 10
(out of 3 (out of 10 (out of 4 (out of 16 (out of 2
participants) participants) participants) participants) participants)
How many
participants had
100.0% (3) 80.0% (8) 50.0% (2) 100.0% (16) 100.0% (2)
adverse reactions
during the study?
How many
participants had
serious adverse 33.3% (1) 0.0% (0) 25.0% (1) 12.5% (2) 0.0% (0)
reactions during
the study?
How many
participants
stopped treatment 0.0% (0) 10.0% (1) 25.0% (1) 0.0% (0) 50.0% (1)
because of adverse
reactions?
How many participants had serious adverse reactions?
There were 11.3% of participants who had serious adverse reactions during the
study. This was 7 out of 62 participants.
There were 53.2% of participants who died during the study. This was 33 out of
62 participants. The study doctors did not think that any of these deaths were
related to AZD1775.
7